Crohn's disease is a chronic in¯ammatory disorder of the gastrointestinal tract, which is thought to result from the effect of environmental factors in a genetically predisposed host. A gene location in the pericentromeric region of chromosome 16, IBD1, that contributes to susceptibility to Crohn's disease has been established through multiple linkage studies 1±6 , but the speci®c gene(s) has not been identi®ed. NOD2, a gene that encodes a protein with homology to plant disease resistance gene products is located in the peak region of linkage on chromosome 16 (ref. 7) . Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease. Wild-type NOD2 activates nuclear factor NF-kB, making it responsive to bacterial lipopolysaccharides; however, this induction was de®cient in mutant NOD2. These results implicate NOD2 in susceptibility to Crohn's disease, and suggest a link between an innate immune response to bacterial components and development of disease.
The idiopathic in¯ammatory bowel diseases (IBDs), which include Crohn's disease (CD) and ulcerative colitis, are chronic disorders of the gastrointestinal tract with unknown aetiology, and with a combined prevalence of about 150±200 cases per 100,000 in western countries 8, 9 . Although the aetiology of IBD is unknown, an abnormal in¯ammatory response directed against enteric microora in a genetically susceptible host has been proposed 10 . Familial clustering of disease and studies of twins strongly suggest that IBD, and in particular CD, is a genetic disorder 11 . Genome-wide searches for IBD-susceptibility genes have resulted in the identi®cation of several loci for CD and/or ulcerative colitis, most notably for CD, in the pericentromeric region of chromosome 16 (IBD1) 1±6 .
NOD2 has structural homology with both the apoptosis regulators Apaf-1/Ced-4 and a class of plant disease resistant (R) gene products 7 . Like the latter gene products, NOD2 comprises an amino-terminal effector domain, a nucleotide-binding domain and leucine-rich repeats (LRRs) (ref. 7) . NOD2 has been mapped to chromosome 16q12 (ref. 7) and is tightly linked to markers D16S3396, D16S416 and D16S419 ( Fig. 1a )Ða site that precisely overlaps with IBD1 (ref. 1). Given the genomic localization and the role of NOD proteins in recognizing bacterial components 12 , we thought that NOD2 might function as a susceptibility gene for CD.
The 12-exon genomic organization of the NOD2 gene was determined by aligning the complementary DNA sequence (AF178930) with one genomic bacterial arti®cial chromosome (BAC) clone, RPI11-327F22 (AC007728) ( Fig. 1a ). All coding exons and¯anking introns were sequenced in 12 affected individuals from pure CD families with increased linkage scores at D16S3396, as well as in 4 case controls. In three CD patients, a cytosine insertion was observed in exon 11 at nucleotide 3020 (3020insC) ( Fig. 1b ). 3020insC resulted in a frameshift at the second nucleotide of codon 1007 (Fig. 1b) , and a Leu1007!Pro substitution in the tenth LRR, followed by a premature stop codon (Fig. 1c ). The predicted truncated NOD2 protein contained 1,007 amino acids instead of the 1,040 amino acids of the wild-type NOD2 protein ( Fig. 1d ).
We used an allele-speci®c polymerase chain reaction (PCR) assay ( Fig. 2 ) to type 3020insC in IBD families and case controls. Analysing only one CD patient per independent family, we observed preferential transmission (Table 1 ) from heterozygous parents to affected children of 3020insC (39 transmissions and 17 nontransmissions; P = 0.0046). Analysing all independent nuclear families by sib-TDT (ftp://lahmed.stanford.edu/pub/aspex/index. html), the empirical P value was similar, P = 0.0007. As expected from linkage studies 2, 5 , no preferential transmission of 3020insC was observed among families with ulcerative colitis (data not shown). As 365 of the 416 independent CD families have several affected individuals, the applicability of these associations to the more common, sporadic cases requires further study.
Additional support for association to CD was provided by case- 
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3020insC control analysis, in which, using one CD individual per independent family, the 3020insC allele frequency among all CD groups was 8.2% ( Table 2 ). The allele frequencies of 3020insC were comparable among Jewish (8.4%) and non-Jewish Caucasians (8.1%). Among case controls (Table 2) , the allele frequency in four separate Caucasian cohorts of 4.0% was signi®cantly lower than in CD patients (P = 0.0018, by large-sample approximations to a twosample binomial test). The allele frequency of the 3020insC among 182 unrelated ulcerative colitis patients was 3.0%, and was signi®cantly lower than the frequency among CD patients (P = 0.0010). The genotype frequencies of 3020insC in unrelated CD individuals were 11 homozygotes, 46 heterozygotes and 359 wild-type homozygotes.
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Among case controls, there were 23 heterozygous individuals, with the remaining being wild-type homozygotes. The genotyperelative risk (GRR) for heterozygous and homozygous 3020insC was 1.5 and 17.6, respectively, as compared with wild-type controls. Given its frequency, 3020insC is unlikely to account completely for the observed evidence of linkage at IBD1, and other variants of NOD2 may confer additional disease risk. For example, two singlenucleotide polymorphisms in NOD2 have been identi®ed, 2722G! C (Gly908!Arg) and 2104C!T (Arg702Trp), which are highly associated with CD by the transmission disequilibrium test (data not shown). Furthermore, other susceptibility genes might also be present in this broad region 1±6 of linkage on chromosome 16. NOD2 has been shown to activate NF-kB and to confer responsiveness to bacterial lipopolysaccharides 7, 12 . To test the ability of wild-type and mutant NOD2 to activate NF-kB, human embryonic kidney (HEK) 293T cells were transiently co-transfected with wildtype or 3020insC plasmids and an NF-kB reporter construct. In the absence of lipopolysaccharide (LPS), expression of both wild-type and mutant NOD2 induced activation of NF-kB ( Fig. 3a) . Notably, equivalent levels of wild-type and mutant NOD2 protein expression (as assessed by immunoblotting of total lysates) resulted in similar levels of NF-kB activation (Fig. 3a) .
Like NOD2, cytosolic plant disease resistant proteins have carboxy-terminal LRRs that are critical for the recognition of pathogen components and induction of pathogen-speci®c responses 13±15 . We therefore compared the ability of wild-type and mutant NOD2 proteins to induce NF-kB activity in response to LPS. Because overexpression of NOD2 induces potent NF-kB activation (Fig. 3a) , we transfected the cells with low amounts of wild-type and mutant NOD2 plasmids to induce similar levels of protein expression and basal NF-kB activity (Fig. 3a) . LPS from various bacteria induced NF-kB activation in cells expressing wild-type NOD2, but not in cells transfected with control plasmid (Fig. 3b) . Signi®cantly, the ability of mutant NOD2 to confer responsiveness to LPS was greatly diminished when compared with wild-type NOD2 (Fig. 3b ). Differential regulation of NOD2 function by LPS from different bacteria was observed (Fig. 3b ), whereas all LPS preparations induced NF-kB activation comparably in cells transfected with Toll-like receptor-4 (TLR-4), a cell-surface receptor for LPS 16 .
The innate immune system regulates the immediate response to microbial pathogens and is initiated by recognition of speci®c pathogen components by receptors in host immune cells 16 . NOD1 and NOD2 seem to function as intracellular receptors for LPS with the LRRs required for responsiveness 12 . We have shown here that truncation of the tenth LRR of NOD2 is associated with CD. Consistent with earlier linkage studies 2,5 , this variant is associated solely with CD, and not with ulcerative colitis. Functional analyses indicate that the disease-associated NOD2 variant is signi®cantly less active than the wild-type protein in conferring responsiveness to bacterial LPS. In plant NOD2 homologues, the LRRs determine the speci®city for pathogen products and alterations in LRRs can result in unresponsiveness to particular pathogens 13±15 . Similarly, genetic variation in the LRRs of TLR4 account for inter-individual differences in bronchial responsiveness to aerosolized LPS 17 .
Several mechanisms can be envisaged to account for susceptibility to CD in individuals carrying this variant. NOD2 is a cytosolic protein whose expression is restricted to monocytes, with no expression detected in lymphocytes 7 . A de®cit in sensing bacteria in monocytes/macrophages might result in an exaggerated in¯ammatory response by the adaptive immune system. A related possibility is that wild-type NOD2 may mediate the induction of cytokines such as interleukin-10 that can downregulate the in¯ammatory response 18, 19 . Finally, variation in the LRRs of plant NOD2 homologues can result in recognition of new speci®cities for pathogen components 13, 14 . Thus, it is also possible that NOD2 variants might act as gain-of-function alleles for unknown pathogens. Our studies implicate NOD2 in susceptibility to CD, and suggest a link between an innate response to bacterial components and development of disease.
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Methods
IBD families
IBD families were ascertained for linkage and association studies (affected child with both parents) through the University of Chicago, the Johns Hopkins Hospital and the University of Pittsburgh. In all cases informed consent for a molecular genetic study was obtained, and the study protocol was approved by the individual institutional review boards.
Allele-speci®c PCR
We used primers framing a 533-base-pair region surrounding the 3020insC allele to amplify genomic DNA isolated from controls and patients by PCR (sense, 59-CTGAGCCTTTGTTGATGAGC-39; antisense, 59-TCTTCAACCACATCCCCATT-39). In addition, each PCR reaction contained two additional primers designed to detect the wildtype allele (sense, 59-CAGAAGCCCTCCTGCAGGCCCT-39) and another primer designed to detect the 3020insC allele (antisense, 59-CGCGTGTCATTCCTTTCAT GGGGC-39). The 3020insC was con®rmed by DNA sequencing. We performed multiplex PCR with all four primers in one tube. PCR products were isolated on 2% agarose gels and visualized with ethidium bromide.
